Accounts Receivable, after Allowance for Credit Loss, Current of ABEONA THERAPEUTICS INC. from 31 Dec 2021 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Summary
ABEONA THERAPEUTICS INC. quarterly Accounts Receivable, after Allowance for Credit Loss, Current in USD history and change rate from 31 Dec 2021 to 31 Dec 2025.
  • ABEONA THERAPEUTICS INC. Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending 31 Dec 2025 was $6,147,000.
Source SEC data
View on sec.gov
Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (USD)
Accounts Receivable, after Allowance for Credit Loss, Current, YoY Quarterly Change (%)

ABEONA THERAPEUTICS INC. Quarterly Accounts Receivable, after Allowance for Credit Loss, Current (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $6,147,000 31 Dec 2025 10-K 17 Mar 2026 2025 FY
Q2 2023 $3,500,000 +$2,500,000 +250% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q2 2022 $1,000,000 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q4 2021 $3,000,000 31 Dec 2021 10-K 29 Mar 2023 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.